Including launch of two new tests to differentiate between COVID-19 and common winter viruses, and between COVID-19 variants
Paris, France and Camberley, UK – 30 September 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&D update.
http://novacyt.com/wp-content/uploads/2021/09/Novacyt-RD-update.pdf